1.Comments on "CYP3AP1*3 Allele Is Associated With Lipid-Lowering Efficacy of Simvastatin and Atorvastatin in Chinese Women"

Hu, M, Mak, VWL, Tom     More...

Hu, M, Mak, VWL, Tomlinson, B     Less

JOURNAL OF CLINICAL PHARMACOLOGY[0091-2700], Published 2012, Volume 52, Issue 11, Pages 1768-1769

收錄情况： WOS SCOPUS

WOS核心合集引用: 1  2022影響因子:  2.9  发表年影響因子:  2.963 

2.CYP3A5 but Not CYP2D6 Polymorphism Contributes Significantly to the Variability in Dextropropoxyphene Disposition

Yin, OQP, Tomlinson,     More...

Yin, OQP, Tomlinson, B, Chow, MSS     Less

JOURNAL OF CLINICAL PHARMACOLOGY[0091-2700], Published 2010, Volume 50, Issue 10, Pages 1136-1141

收錄情况： WOS SCOPUS

WOS核心合集引用: 1  2022影響因子:  2.9  发表年影響因子:  3.590 

3.Effects of Concomitant Therapy with Diltiazem on the Lipid Responses to Simvastatin in Chinese Subjects

You, JHS, Chan, WKY,     More...

You, JHS, Chan, WKY, Chung, PFP, Hu, M, Tomlinson, B     Less

JOURNAL OF CLINICAL PHARMACOLOGY[0091-2700], Published 2010, Volume 50, Issue 10, Pages 1151-1158

收錄情况： WOS SCOPUS

WOS核心合集引用: 6  2022影響因子:  2.9  发表年影響因子:  3.590 

4.Effects of the angiotensin II type 1 receptor antagonist valsartan on the expression of superoxide dismutase in hypertensive patients

Yang, HY, Kao, PF, C     More...

Yang, HY, Kao, PF, Chen, TH, Tomlinson, B, Ko, WC, Chan, P     Less

JOURNAL OF CLINICAL PHARMACOLOGY[0091-2700], Published 2007, Volume 47, Issue 3, Pages 397-403

收錄情况： WOS SCOPUS

WOS核心合集引用: 10  2022影響因子:  2.9  发表年影響因子:  2.993 

5.Variability in renal clearance of substrates for renal transporters in Chinese subjects

Yin, OQR, Tomlinson,     More...

Yin, OQR, Tomlinson, B, Chow, MSS     Less

JOURNAL OF CLINICAL PHARMACOLOGY[0091-2700], Published 2006, Volume 46, Issue 2, Pages 157-163

收錄情况： WOS SCOPUS

WOS核心合集引用: 32  2022影響因子:  2.9  发表年影響因子:  3.058 

6.Pharmacokinetics of sulphasalazine and sulphapyridine: Relation to N-acetyltransferase 2 genotype in Chinese subjects

Yin, OOP, Tomlinson,     More...

Yin, OOP, Tomlinson, B, Chow, MSS     Less

JOURNAL OF CLINICAL PHARMACOLOGY[0091-2700], Published 2006, Volume 46, Issue 9, Pages 1093-1093

收錄情况： WOS

WOS核心合集引用: 0  2022影響因子:  2.9  发表年影響因子:  3.058 

7.Effects of combined CYP2C19 and 2D6 polymorphisms on the pharmacokinetics of fluoxetine in Chinese subjects

Yin, OQP, Lam, V, To     More...

Yin, OQP, Lam, V, Tomlinson, B, Chow, MSS     Less

JOURNAL OF CLINICAL PHARMACOLOGY[0091-2700], Published 2006, Volume 46, Issue 9, Pages 1093_1093

收錄情况： WOS

WOS核心合集引用: 0  2022影響因子:  2.9  发表年影響因子:  3.058 

8.Omeprazole as a CYP2C19 marker in Chinese subjects: Assessment of its gene-dose effect and intrasubject variability

Yin, OQR, Tomlinson,     More...

Yin, OQR, Tomlinson, B, Chow, AHL, Waye, MMY, Chow, MSS     Less

JOURNAL OF CLINICAL PHARMACOLOGY[0091-2700], Published 2004, Volume 44, Issue 6, Pages 582-589

收錄情况： WOS SCOPUS

WOS核心合集引用: 44  2022影響因子:  2.9  发表年影響因子:  2.273 

9.Genetic contribution to variability in renal drug clearance in Chinese subjects

Yin, OQP, Tomlinson,     More...

Yin, OQP, Tomlinson, B, Chow, MSS     Less

JOURNAL OF CLINICAL PHARMACOLOGY[0091-2700], Published 2004, Volume 44, Issue 10, Pages 1198-1198

收錄情况： WOS

WOS核心合集引用: 0  2022影響因子:  2.9  发表年影響因子:  2.273 

10.Interindividual and intraindividual variability of the urinary 6 beta-hydroxycortisol/cortisol ratio in Chinese subjects implications of its use fair evaluating CYP3A activity

Yin, OQR, Shi, XJ, T     More...

Yin, OQR, Shi, XJ, Tomlinson, B, Chow, MSS     Less

JOURNAL OF CLINICAL PHARMACOLOGY[0091-2700], Published 2004, Volume 44, Issue 12, Pages 1412-1417

收錄情况： WOS SCOPUS

WOS核心合集引用: 22  2022影響因子:  2.9  发表年影響因子:  2.273 

11.Inter-individual variability in loratadine pharmacokinetics in Chinese subjects: Relationship with CYP2D6 genotype

Yin, OQP, Shi, XJ, T     More...

Yin, OQP, Shi, XJ, Tomlinson, B, Chow, MSS     Less

JOURNAL OF CLINICAL PHARMACOLOGY[0091-2700], Published 2003, Volume 43, Issue 9, Pages 1031-1031

收錄情况： WOS

WOS核心合集引用: 0  2022影響因子:  2.9  发表年影響因子:  1.945 

12.Pharmacokinetics and metabolism of omeprazole in Chinese subjects

Yin, OQP, Tsang, SY,     More...

Yin, OQP, Tsang, SY, Tsang, YY, Tomlinson, B, Chow, AHL, Chow, MSS     Less

JOURNAL OF CLINICAL PHARMACOLOGY[0091-2700], Published 2002, Volume 42, Issue 9, Pages 1069-1069

收錄情况： WOS

WOS核心合集引用: 0  2022影響因子:  2.9  发表年影響因子:  1.960 

13.Toxicity of complementary therapies: An Eastern perspective

Tomlinson, B, Chan,     More...

Tomlinson, B, Chan, TYK, Chan, JCN, Critchley, JAJH, But, PPH     Less

JOURNAL OF CLINICAL PHARMACOLOGY[0091-2700], Published 2000, Volume 40, Issue 5, Pages 451-456

收錄情况： WOS SCOPUS

WOS核心合集引用: 63  2022影響因子:  2.9  发表年影響因子:  2.003 

14.Antioxidant effects of Chinese traditional medicine: Focus on trilinolein isolated from the Chinese herb sanchi (Panax pseudoginseng)

Chan, P, Tomlinson,     More...

Chan, P, Tomlinson, B     Less

JOURNAL OF CLINICAL PHARMACOLOGY[0091-2700], Published 2000, Volume 40, Issue 5, Pages 457-461

收錄情况： WOS SCOPUS

WOS核心合集引用: 21  2022影響因子:  2.9  发表年影響因子:  2.003 

15.Alternative therapies and medical science: Designing clinical trials of alternative/complementary medicines - Is evidence-based traditional Chinese medicine attainable?

Critchley, JAJH, Zha     More...

Critchley, JAJH, Zhang, Y, Suthisisang, CC, Chan, TYK, Tomlinson, B     Less

JOURNAL OF CLINICAL PHARMACOLOGY[0091-2700], Published 2000, Volume 40, Issue 5, Pages 462-467

收錄情况： WOS SCOPUS

WOS核心合集引用: 27  2022影響因子:  2.9  发表年影響因子:  2.003 

16.Double-blind comparison of losartan, lisinopril, and metolazone in elderly hypertensive patients with previous angiotensin-converting enzyme inhibitor-induced cough

Chan, P, Tomlinson,     More...

Chan, P, Tomlinson, B, Huang, TY, Ko, JT, Lin, TS, Lee, YS     Less

JOURNAL OF CLINICAL PHARMACOLOGY[0091-2700], Published 1997, Volume 37, Issue 3, Pages 253-257

收錄情况： WOS SCOPUS

WOS核心合集引用: 38  2022影響因子:  2.9  发表年影響因子:  1.576 

17.Short-term safety and efficacy of low-dose simvastatin in elderly patients with hypertensive hypercholesterolemia and fasting hyperinsulinemia

Chan, P, Huang, TY,     More...

Chan, P, Huang, TY, Tomlinson, B, Lee, C, Lee, YS     Less

JOURNAL OF CLINICAL PHARMACOLOGY[0091-2700], Published 1997, Volume 37, Issue 6, Pages 496-501

收錄情况： WOS SCOPUS

WOS核心合集引用: 14  2022影響因子:  2.9  发表年影響因子:  1.576 

18.Effectiveness and safety of low-dose pravastatin and squalene, alone and in combination, in elderly patients with hypercholesterolemia

Chan, P, Tomlinson,     More...

Chan, P, Tomlinson, B, Lee, CB, Lee, YS     Less

JOURNAL OF CLINICAL PHARMACOLOGY[0091-2700], Published 1996, Volume 36, Issue 5, Pages 422-427

收錄情况： WOS SCOPUS

WOS核心合集引用: 69  2022影響因子:  2.9